Tmem119 is involved in bone anabolic effects of PTH through enhanced osteoblastic bone formation in mice
Bone · 2024
DOI: 10.1016/j.bone.2024.117040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2024. Verfasst von Naoyuki Kawao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osakasayama, Japan. Hauptthemen laut MEDLINE: Parathyroid Hormone, Anabolic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Salt Science Research Foundation, Kindai University.
Abstract (Originalsprache)
The intermittent administration of parathyroid hormone (PTH) exerts potent bone anabolic effects, which increase bone mineral density (BMD) and reduce fracture risk in osteoporotic patients. However, the underlying mechanisms remain unclear. Tmem119 has been proposed as a factor that is closely linked to the osteoblast phenotype, and we previously reported that PTH enhanced the expression of Tmem119 in mouse osteoblastic cells. However, roles of Tmem119 in the bone anabolic effects of PTH in vivo remain unknown. We herein investigated the roles of Tmem119 in bone anabolic effects of PTH using Tmem119-deficient mice. Tmem119 deficiency significantly reduced PTH-induced increases in trabecular bone volume and cortical BMD of femurs. Effects of Tmem119 deficiency on bone mass seemed predominant in female mice. Histomorphometric analyses with calcein labeling showed that Tmem119 deficiency significantly attenuated PTH-induced increases in the rates of bone formation and mineralization as well as numbers of osteoblasts. Moreover, Tmem119 deficiency significantly blunted PTH-induced decreases in phosphorylation of β-catenin and increases in alkaline phosphatase activity in osteoblasts. In conclusion, the present results indicate that Tmem119 is involved in bone anabolic effects of PTH through osteoblastic bone formation partly related to canonical Wnt-β-catenin signaling in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osakasayama, Japan.
- Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osakasayama, Japan; Department of Orthopaedic Surgery, Kindai University Faculty of Medicine, Osakasayama, Japan.
- Life Science Research Institute, Kindai University, Osakasayama, Japan.
- Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osakasayama, Japan. Electronic address: hkaji@med.kindai.ac.jp.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Salt Science Research Foundation
- Kindai University
Zitieren
APA
Kawao, N., Matsumura, D., Yamada, A., Okumoto, K., Ohira, T., Mizukami, Y., Hashimoto, D., & Kaji, H. (2024). Tmem119 is involved in bone anabolic effects of PTH through enhanced osteoblastic bone formation in mice. Bone. https://doi.org/10.1016/j.bone.2024.117040
Vancouver
Kawao N, Matsumura D, Yamada A, Okumoto K, Ohira T, Mizukami Y, et al. Tmem119 is involved in bone anabolic effects of PTH through enhanced osteoblastic bone formation in mice. Bone. 2024. doi:10.1016/j.bone.2024.117040
BibTeX
@article{Kawao2024,
author = {Kawao, Naoyuki and Matsumura, Daichi and Yamada, Ayaka and Okumoto, Katsumi and Ohira, Takashi and Mizukami, Yuya and Hashimoto, Daiki and Kaji, Hiroshi},
title = {Tmem119 is involved in bone anabolic effects of PTH through enhanced osteoblastic bone formation in mice},
journal = {Bone},
year = {2024},
doi = {10.1016/j.bone.2024.117040}
}
EUVIMED